Blog
RSS FeedPosted by Michael Wonder on 23 Aug 2017
Health Minister hears consumer case for health reform
23 August 2017 - Healthcare consumers have today put the case to Health Minister, Greg Hunt, for his National Health ...
Posted by Michael Wonder on 22 Aug 2017
What should patients be told about non-inferiority studies?
21 August 2017 - A non-inferiority trial is a study in which a new treatment is compared with an existing, already ...
Posted by Michael Wonder on 07 Aug 2017
Promoting consumer involvement in medicine decisions welcomed
7 August 2017 - The appointment of consumer leader, Jo Watson, as the inaugural deputy chairperson of the Pharmaceutical Benefits ...
Posted by Michael Wonder on 01 Aug 2017
Sharing patient input submissions for the CDR program
1 August 2017 - Since February 2014, CADTH has shared patient input submissions on our website, when permission has been ...
Posted by Michael Wonder on 27 Jul 2017
FDA sets inaugural meeting of first-ever patient engagement advisory committee
25 July 2017 - Imagine checking your blood sugar levels several times a day with a glucose meter to keep your ...
Posted by Michael Wonder on 12 Jul 2017
The rise and fall in out-of-pocket costs in Australia: an analysis of the strengthening Medicare reforms
12 July 2017 - After a period of steady decline, out-of-pocket (OOP) costs for general practitioner (GP) consultations in Australia began ...
Posted by Michael Wonder on 05 Jun 2017
Top medicines panel benefits from second consumer representative
2 June 2017 - The appointment of a second consumers representative to the Pharmaceutical Benefits Advisory Committee recognises the value ...
Posted by Michael Wonder on 22 May 2017
Another voice: Patients have a right to the treatments ordered by doctors
22 May 2017 - For too long, insurance-backed groups have been given enormous power to overrule doctors’ orders and make ...
Posted by Michael Wonder on 18 May 2017
Clinical trial participants should have a say in new drug pricing
18 May 2017 - People who volunteer to participate in clinical trials of new drugs provide a valuable service to ...
Posted by Michael Wonder on 16 May 2017
New guidance for patient group partners taking part in SMC Committee meetings
15 May 2017 - From June 2017, the SMC will be introducing new processes to improve how they involve patient ...
Posted by Michael Wonder on 09 May 2017
Patient voice prompts new medicines funding
7 May 2017 - Medicines New Zealand is pleased that the New Zealand Government has today announced an additional investment ...
Posted by Michael Wonder on 08 May 2017
Involving patients in discussions on benefits and risks of medicines
8 May 2017 - EMA publishes report on CHMP pilot project. ...
Posted by Michael Wonder on 03 May 2017
Patient financial assistance programs: a path to affordability or a barrier to accessible cancer care?
1 May 2017 - Prognosis for many patients with cancer is improving as a result of advances in precision, molecularly targeted ...
Posted by Michael Wonder on 27 Apr 2017
Using the Budget to improve patient experience
27 April 2017 - Patient Experience Week coming two weeks before the Federal Budget provides a timely opportunity for voters ...
Posted by Michael Wonder on 19 Apr 2017
Reevaluating eligibility criteria — balancing patient protection and participation in oncology trials
19 April 2017 - Specific patient populations are often excluded from oncology trials without clear reasons, which renders results less clearly ...